These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 26277546

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ.
    Childs SK, Chen YH, Duggan MM, Golshan M, Pochebit S, Punglia RS, Wong JS, Bellon JR.
    Int J Radiat Oncol Biol Phys; 2013 Mar 15; 85(4):948-52. PubMed ID: 22975615
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1514-21. PubMed ID: 16005576
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Analyzing the risk of recurrence after mastectomy for DCIS: a new use for the USC/Van Nuys Prognostic Index.
    Kelley L, Silverstein M, Guerra L.
    Ann Surg Oncol; 2011 Feb 01; 18(2):459-62. PubMed ID: 20859695
    [Abstract] [Full Text] [Related]

  • 9. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C, Giard S, Buttarelli M, Blanchot J, Classe JM, Baron M, Monnier B, Houvenaeghel G.
    Breast J; 2008 Feb 01; 14(2):135-40. PubMed ID: 18315691
    [Abstract] [Full Text] [Related]

  • 10. Outcomes in patients treated with mastectomy for ductal carcinoma in situ.
    Owen D, Tyldesley S, Alexander C, Speers C, Truong P, Nichol A, Wai ES.
    Int J Radiat Oncol Biol Phys; 2013 Mar 01; 85(3):e129-34. PubMed ID: 23195778
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.
    Dieterich M, Hartwig F, Stubert J, Klöcking S, Kundt G, Stengel B, Reimer T, Gerber B.
    Breast; 2014 Aug 01; 23(4):346-51. PubMed ID: 24559611
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.
    Prescrire Int; 2013 Dec 01; 22(144):298-303. PubMed ID: 24600734
    [Abstract] [Full Text] [Related]

  • 20. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem?
    Sacchini V, Pinotti JA, Barros AC, Luini A, Pluchinotta A, Pinotti M, Boratto MG, Ricci MD, Ruiz CA, Nisida AC, Veronesi P, Petit J, Arnone P, Bassi F, Disa JJ, Garcia-Etienne CA, Borgen PI.
    J Am Coll Surg; 2006 Nov 01; 203(5):704-14. PubMed ID: 17084333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.